Cargando…

SARS-CoV-2 vaccine development and how Brazil is contributing

The SARS-CoV-2 coronavirus pandemic calls for coordinated efforts by the scientific community for the development of vaccines. The most advanced strategies have focused on modifications of technologies that were already under development for other viruses, such as SARS, MERS, and even Influenza. Cla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanno, Alex I., Barbosa, Mayra M.F., Moraes, Luana, Leite, Luciana C.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Genética 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020624/ https://www.ncbi.nlm.nih.gov/pubmed/33818582 http://dx.doi.org/10.1590/1678-4685-GMB-2020-0320

Ejemplares similares

Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil
por: Siqueira, Priscila C., et al.
Publicado: (2022)

SARS-CoV-2 vaccination in CLL: how often is enough?
por: Mellinghoff, Sibylle C., et al.
Publicado: (2022)

Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil
por: Giovanetti, Marta, et al.
Publicado: (2022)

Seroepidemiology of SARS-CoV-2 on a partially vaccinated island in Brazil: Determinants of infection and vaccine response
por: Cerbino-Neto, José, et al.
Publicado: (2022)

Primary and Memory Response of Human Monocytes to Vaccines: Role of Nanoparticulate Antigens in Inducing Innate Memory
por: Barbosa, Mayra M. Ferrari, et al.
Publicado: (2021)

Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis
por: Broset, Esther, et al.
Publicado: (2021)

Evolution and epidemic spread of SARS-CoV-2 in Brazil
por: Candido, Darlan S., et al.
Publicado: (2020)

CRISPR/Cas9 Approach to Generate an Auxotrophic BCG Strain for Unmarked Expression of LTAK63 Adjuvant: A Tuberculosis Vaccine Candidate
por: Moraes, Luana, et al.
Publicado: (2022)

Brazil’s COVID-19 Epicenter in Manaus: How Much of the Population Has Already Been Exposed and Are Vulnerable to SARS-CoV-2?
por: Ferrante, Lucas, et al.
Publicado: (2021)

Dynamics of SARS-CoV-2 Variants of Concern in Vaccination Model City in the State of Sao Paulo, Brazil
por: Slavov, Svetoslav Nanev, et al.
Publicado: (2022)

Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?
por: Tang, Patrick Chun Hean, et al.
Publicado: (2022)

Modelling policy combinations of vaccination and transmission suppression of SARS-CoV-2 in Rio de Janeiro, Brazil
por: Valiati, Naiara C.M., et al.
Publicado: (2021)

Early pneumococcal clearance in mice induced by systemic immunization with recombinant BCG PspA-PdT prime and protein boost correlates with cellular and humoral immune response in bronchoalveolar fluids (BALF)
por: Goulart, Cibelly, et al.
Publicado: (2019)

Optimization of Expression and Purification of Schistosoma mansoni Antigens in Fusion with Rhizavidin
por: Barbosa, Mayra M. F., et al.
Publicado: (2021)

Post-acute COVID-19 syndrome after reinfection and vaccine breakthrough by the SARS-CoV-2 Gamma variant in Brazil
por: Penetra, Stephanie L.S., et al.
Publicado: (2022)

Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil
por: Estofolete, Cassia F., et al.
Publicado: (2021)

Case Report: SARS-CoV-2 Gamma Isolation From Placenta of a Miscarriage in Midwest, Brazil
por: Fernandez, Zoraida, et al.
Publicado: (2022)

SARS-CoV-2–Specific Vaccine Candidates; the Contribution of Structural Vaccinology
por: Pack, Su Min, et al.
Publicado: (2022)

SARS-CoV-2 Seroconversion in Response to Infection and Vaccination: a Time Series Local Study in Brazil
por: Huergo, Luciano F., et al.
Publicado: (2022)

20-Month monitoring of SARS-CoV-2 in wastewater of Curitiba, in Southern Brazil
por: Belmonte-Lopes, Ricardo, et al.
Publicado: (2023)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants
por: Guo, Ying, et al.
Publicado: (2022)

Respiratory Viral Shedding in Healthcare Workers Reinfected with SARS-CoV-2, Brazil, 2020
por: Amorim, Mariene R., et al.
Publicado: (2021)

Cluster of SARS-CoV-2 Gamma Variant Infections, Parintins, Brazil, March 2021
por: da Silva, Juliana F., et al.
Publicado: (2022)

How Losing Sleep Following Vaccination May Weaken the Response to SARS-CoV Vaccines
por: Akhtar, Nasreen, et al.
Publicado: (2022)

SARS-CoV-2 Vaccines and the Skin()
por: Galván-Casas, C., et al.
Publicado: (2021)

SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil
por: Freire-Neto, Francisco P., et al.
Publicado: (2022)

SARS-CoV-2 epidemic in Brazil: how the displacement of variants has driven distinct epidemic waves
por: Alcantara, Luiz Carlos Junior, et al.
Publicado: (2022)

Government inaction on COVID-19 vaccines contributes to the persistence of childism in Brazil
por: Barberia, Lorena G., et al.
Publicado: (2022)

Assessment of Anti-SARS-CoV-2 Antibodies Post-Coronavac Vaccination in the Amazon Region of Brazil
por: Bichara, Carlos David Araújo, et al.
Publicado: (2021)

SARS-CoV-2 variant N.9 identified in Rio de Janeiro, Brazil
por: Tort, Luis Fernando Lopez, et al.
Publicado: (2021)

Serial interval distribution of SARS-CoV-2 infection in Brazil
por: Prete, Carlos A, et al.
Publicado: (2020)

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
por: Gorman, Matthew J., et al.
Publicado: (2021)

Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
por: Souza, William M, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 and Vaccination Coverage among Residents of a Lower-Middle-Class Population in the Federal District, Brazil
por: Nogueira de Brito, Raíssa, et al.
Publicado: (2023)

Incipient Parallel Evolution of SARS-CoV-2 Deltacron Variant in South Brazil
por: Sant’Anna, Fernando Hayashi, et al.
Publicado: (2023)

How did SARS-CoV-2 variants impact the elective and emergency surgeries?
por: Barbosa, Gabriela, et al.
Publicado: (2023)

Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study
por: Aikawa, Nadia E, et al.
Publicado: (2022)

Landscape and Selection of Vaccine Epitopes in SARS-CoV-2
por: Smith, Christof C., et al.
Publicado: (2020)

Adaptive SIR model for propagation of SARS-CoV-2 in Brazil
por: dos Santos, I.F.F., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3272aei279bhk78updppfvcfb3